-
公开(公告)号:US20100310561A1
公开(公告)日:2010-12-09
申请号:US12522114
申请日:2008-06-03
申请人: Keith Canada , Uwe Schoenbeck , Eugene R. Hickey , Adam Mezo , Kevin McDonnell
发明人: Keith Canada , Uwe Schoenbeck , Eugene R. Hickey , Adam Mezo , Kevin McDonnell
IPC分类号: A61K39/395 , C07K16/00 , C07K14/00 , C12N15/12 , C12N15/63 , C12N5/00 , C12P21/00 , A61P9/00 , A61P31/04 , A61P11/00 , A61P13/12
摘要: Natriuretic peptide fusion proteins comprising natriuretic peptides linked to antibody Fc domains, nucleic acid molecules encoding the fusion proteins disclosed herein, expression vectors expressing said fusion proteins, pharmaceutical compositions comprising said fusion proteins, and methods for their therapeutic use are disclosed.
摘要翻译: 公开了包含与抗体Fc结构域连接的利尿钠肽,编码本文公开的融合蛋白的核酸分子,表达所述融合蛋白的表达载体,包含所述融合蛋白的药物组合物及其治疗用途的利钠肽融合蛋白。
-
公开(公告)号:US09090696B2
公开(公告)日:2015-07-28
申请号:US14046121
申请日:2013-10-04
申请人: Rachel Rebecca Barrett , Scott Ronald Brodeur , Keith Canada , Tobias Litzenburger , Sanjaya Singh
发明人: Rachel Rebecca Barrett , Scott Ronald Brodeur , Keith Canada , Tobias Litzenburger , Sanjaya Singh
CPC分类号: C07K16/2878 , A61K9/0019 , A61K2039/505 , C07K1/22 , C07K2317/24 , C07K2317/33 , C07K2317/51 , C07K2317/515 , C07K2317/53 , C07K2317/565 , C07K2317/71 , C07K2317/73 , C07K2317/732 , C07K2317/76 , C07K2317/92 , C07K2317/94
摘要: The present invention relates to new humanized antagonistic anti-CD40 antibodies and therapeutic and diagnostic methods and compositions for using the same.
摘要翻译: 本发明涉及新的人源化拮抗性抗CD40抗体及其使用的治疗和诊断方法及组合物。
-
3.Methods of using antibodies during anticoagulant therapy of dabigatran and/or related compounds 有权
标题翻译: 在达比加群和/或相关化合物的抗凝治疗期间使用抗体的方法公开(公告)号:US09034822B2
公开(公告)日:2015-05-19
申请号:US13916994
申请日:2013-06-13
申请人: Joanne Van Ryn , John Edward Park , Norbert Hauel , Ulrich Kunz , Tobias Litzenburger , Keith Canada , Sanjaya Singh , Alisa Waterman
发明人: Joanne Van Ryn , John Edward Park , Norbert Hauel , Ulrich Kunz , Tobias Litzenburger , Keith Canada , Sanjaya Singh , Alisa Waterman
IPC分类号: A61K39/395 , C07K16/44
CPC分类号: C07K16/44 , A61K31/4439 , A61K39/39583 , C07K2317/24 , C07K2317/54 , C07K2317/55 , C07K2317/565 , C07K2317/569 , C07K2317/622 , C07K2317/626 , C07K2317/76 , G01N33/86 , G01N2500/02 , G01N2500/10
摘要: The present invention relates to antibody molecules against anticoagulants, in particular dabigatran, and their use as antidotes of such anticoagulants.
摘要翻译: 本发明涉及针对抗凝剂,特别是达比加群的抗体分子,以及它们作为这种抗凝剂的解毒剂的用途。
-
公开(公告)号:US09441036B2
公开(公告)日:2016-09-13
申请号:US14302986
申请日:2014-06-12
申请人: Rachel Rebecca Barrett , Keith Canada , Katrina Mary Catron , Robert Copenhaver , Lee Edward Frego , Ernest Lee Raymond , Sanjaya Singh , Xiangyang Zhu
发明人: Rachel Rebecca Barrett , Keith Canada , Katrina Mary Catron , Robert Copenhaver , Lee Edward Frego , Ernest Lee Raymond , Sanjaya Singh , Xiangyang Zhu
IPC分类号: C07K16/24 , C12N15/113 , C12N15/24 , A61K39/395 , A61K39/00
CPC分类号: C07K16/244 , A61K2039/505 , C07K2317/24 , C07K2317/34 , C07K2317/565 , C07K2317/76 , C07K2317/92 , C07K2317/94 , C12N15/113
摘要: The present invention relates to anti-IL-23p19 binding compounds, in particular new humanized anti-IL-23p19 antibodies and therapeutic and diagnostic methods and compositions for using the same.
摘要翻译: 本发明涉及抗IL-23p19结合化合物,特别是新的人源化抗IL-23p19抗体以及用于其的治疗和诊断方法和组合物。
-
5.Anticoagulant antidotes comprising antibodies that bind dabigatran and/or related compounds and methods of use thereof 有权
标题翻译: 抗凝血剂解毒剂,其包含结合达比加群和/或相关化合物的抗体及其使用方法公开(公告)号:US08821871B2
公开(公告)日:2014-09-02
申请号:US13432296
申请日:2012-03-28
申请人: Joanne Van Ryn , Keith Canada , Robert Copenhaver , Norbert Hauel , Tobias Litzenburger , Christopher Ronald Sarko , Sanjaya Singh , Alisa K. Waterman
发明人: Joanne Van Ryn , Keith Canada , Robert Copenhaver , Norbert Hauel , Tobias Litzenburger , Christopher Ronald Sarko , Sanjaya Singh , Alisa K. Waterman
IPC分类号: A61K39/395 , C07K16/44
CPC分类号: C07K16/44 , A61K31/4439 , A61K39/395 , A61K39/39583 , A61K2039/505 , C07K2299/00 , C07K2317/14 , C07K2317/21 , C07K2317/24 , C07K2317/55 , C07K2317/56 , C07K2317/565 , C07K2317/76 , C07K2317/92 , A61K2300/00
摘要: The present invention relates to antibody molecules against anticoagulants, in particular dabigatran, and their use as antidotes of such anticoagulants.
摘要翻译: 本发明涉及针对抗凝剂,特别是达比加群的抗体分子,以及它们作为这种抗凝剂的解毒剂的用途。
-
公开(公告)号:US20120282269A1
公开(公告)日:2012-11-08
申请号:US13287208
申请日:2011-11-02
申请人: Rachel Rebecca Barrett , Keith Canada , Katrina Mary Catron , Robert Copenhaver , Lee Edward Frego , Ernest Lee Raymond , Sanjaya Singh , Xiangyang Zhu
发明人: Rachel Rebecca Barrett , Keith Canada , Katrina Mary Catron , Robert Copenhaver , Lee Edward Frego , Ernest Lee Raymond , Sanjaya Singh , Xiangyang Zhu
IPC分类号: A61K39/395 , C07K16/46 , C12N15/13 , A61P35/00 , A61P29/00 , A61P37/06 , A61P3/00 , C07K16/24 , C12N5/071
CPC分类号: C07K16/244 , A61K2039/505 , C07K2317/24 , C07K2317/34 , C07K2317/565 , C07K2317/76 , C07K2317/92 , C07K2317/94 , C12N15/113
摘要: The present invention relates to anti-IL-23p19 binding compounds, in particular new humanized anti-IL-23p19 antibodies and therapeutic and diagnostic methods and compositions for using the same.
摘要翻译: 本发明涉及抗IL-23p19结合化合物,特别是新的人源化抗IL-23p19抗体以及用于其的治疗和诊断方法和组合物。
-
公开(公告)号:US08591900B2
公开(公告)日:2013-11-26
申请号:US13075303
申请日:2011-03-30
申请人: Rachel Rebecca Barrett , Scott Ronald Brodeur , Keith Canada , Tobias Litzenburger , Sanjaya Singh
发明人: Rachel Rebecca Barrett , Scott Ronald Brodeur , Keith Canada , Tobias Litzenburger , Sanjaya Singh
IPC分类号: A61K39/395 , C07K16/28
CPC分类号: C07K16/2878 , A61K9/0019 , A61K2039/505 , C07K1/22 , C07K2317/24 , C07K2317/33 , C07K2317/51 , C07K2317/515 , C07K2317/53 , C07K2317/565 , C07K2317/71 , C07K2317/73 , C07K2317/732 , C07K2317/76 , C07K2317/92 , C07K2317/94
摘要: The present invention relates to new humanized antagonistic anti-CD40 antibodies and therapeutic and diagnostic methods and compositions for using the same.
摘要翻译: 本发明涉及新的人源化拮抗性抗CD40抗体及其使用的治疗和诊断方法及组合物。
-
公开(公告)号:US20120093814A1
公开(公告)日:2012-04-19
申请号:US13254887
申请日:2010-03-30
申请人: Keith Canada , Sanjaya Singh , Xiangyang Zhu
发明人: Keith Canada , Sanjaya Singh , Xiangyang Zhu
IPC分类号: A61K39/395 , A61P9/12 , A61P9/00 , C07K16/00 , C07H21/04
CPC分类号: C07K14/58 , C07K2317/20 , C07K2317/52 , C07K2319/30
摘要: The present invention relates to therapeutic peptides and proteins fused to a canine antibody Fc domain. Methods and compositions of using the same are described.
摘要翻译: 本发明涉及与犬抗体Fc结构域融合的治疗性肽和蛋白质。 描述了使用该方法和组合物的方法和组合物。
-
公开(公告)号:US08778346B2
公开(公告)日:2014-07-15
申请号:US13287208
申请日:2011-11-02
申请人: Rachel Rebecca Barrett , Keith Canada , Katrina Mary Catron , Robert Copenhaver , Lee Edward Frego , Ernest Lee Raymond , Sanjaya Singh , Xiangyang Zhu
发明人: Rachel Rebecca Barrett , Keith Canada , Katrina Mary Catron , Robert Copenhaver , Lee Edward Frego , Ernest Lee Raymond , Sanjaya Singh , Xiangyang Zhu
IPC分类号: A61K39/395 , C07K16/46 , C07K16/24 , A61K39/00
CPC分类号: C07K16/244 , A61K2039/505 , C07K2317/24 , C07K2317/34 , C07K2317/565 , C07K2317/76 , C07K2317/92 , C07K2317/94 , C12N15/113
摘要: The present invention relates to anti-IL-23p19 binding compounds, in particular new humanized anti-IL-23p19 antibodies and therapeutic and diagnostic methods and compositions for using the same.
摘要翻译: 本发明涉及抗IL-23p19结合化合物,特别是新的人源化抗IL-23p19抗体以及用于其的治疗和诊断方法和组合物。
-
10.Anticoagulant antidotes comprising antibodies that bind dabigatran and/or related compounds 有权
标题翻译: 抗凝血剂解毒剂,其包含结合达比加群和/或相关化合物的抗体公开(公告)号:US08486398B2
公开(公告)日:2013-07-16
申请号:US13010403
申请日:2011-01-20
申请人: Joanne Van Ryn , John Edward Park , Norbert Hauel , Ulrich Kunz , Tobias Litzenburger , Keith Canada , Sanjaya Singh , Alisa Waterman
发明人: Joanne Van Ryn , John Edward Park , Norbert Hauel , Ulrich Kunz , Tobias Litzenburger , Keith Canada , Sanjaya Singh , Alisa Waterman
IPC分类号: A61K39/395
CPC分类号: C07K16/44 , A61K31/4439 , A61K39/39583 , C07K2317/24 , C07K2317/54 , C07K2317/55 , C07K2317/565 , C07K2317/569 , C07K2317/622 , C07K2317/626 , C07K2317/76 , G01N33/86 , G01N2500/02 , G01N2500/10
摘要: The present invention relates to antibody molecules against anticoagulants, in particular dabigatran, and their use as antidotes of such anticoagulants.
摘要翻译: 本发明涉及针对抗凝剂,特别是达比加群的抗体分子,以及它们作为这种抗凝剂的解毒剂的用途。
-
-
-
-
-
-
-
-
-